Reacciones alérgicas y pseudoalérgicas en las intervenciones quirûrgicas con anestesia general

Allergologia et Immunopathologia

Volumn 28, Issue 1, 2000, Pages 24-36

  Sanchez Palacios A ^a,c   Ortiz Ponce, M ^a   Rodriguez Perez A ^b  

^a Hospital General   (Spain)

^b Virgen del Pino Hospital   (Spain)

^c HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCURONIUM; ALFENTANIL; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BENZOQUINONE; DIAZEPAM; DROPERIDOL; DROPERIDOL PLUS FENTANYL; ETOMIDATE; GALLAMINE; HALOPERIDOL; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; KETAMINE; LATEX; METHOHEXITAL; MORPHINE; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; SUFENTANIL; SUXAMETHONIUM; THIOPENTAL; TRYPTASE; UNINDEXED DRUG; VECURONIUM; MUSCLE RELAXANT AGENT;

ALLERGIC REACTION; BRONCHOSPASM; CLINICAL PROTOCOL; DRUG CROSS REACTIVITY; FOOD DRUG INTERACTION; GASTROINTESTINAL SYMPTOM; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HISTAMINE RELEASE; HUMAN; LARYNX EDEMA; MEDICAL SOCIETY; REVIEW; SKIN DEFECT; SPINA BIFIDA; ALLERGY; ANAPHYLAXIS; BASOPHIL DEGRANULATION TEST; CHEMICALLY INDUCED DISORDER; CROSS REACTION; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG ERUPTION; DRUG HYPERSENSITIVITY; FEMALE; IMMUNE COMPLEX DISEASE; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; INCIDENCE; MALE; PEROPERATIVE CARE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREMEDICATION; PREOPERATIVE CARE; RISK FACTOR; SKIN TEST;

ANAPHYLAXIS; ANESTHESIA, GENERAL; ANESTHETICS, GENERAL; BASOPHIL DEGRANULATION TEST; CROSS REACTIONS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; HUMANS; IMMUNE COMPLEX DISEASES; IMMUNOLOGIC TECHNIQUES; INCIDENCE; INTRAOPERATIVE CARE; INTRAOPERATIVE COMPLICATIONS; LATEX HYPERSENSITIVITY; MALE; NEUROMUSCULAR AGENTS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES; PREANESTHETIC MEDICATION; PREOPERATIVE CARE; RISK FACTORS; SKIN TESTS;

EID: 0034028324     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (124)

1. Laxenaire ME, Moniret-Vautrin Dam Boileau S, Mueller R. Adverse reactions to intravenous agents in anaesthesia in France. Klin Wochenschr 1982;60:1006-9.
2. Fisher MM, Blado BA. The incidence and clinical features of anaphylactic reactions during anaesthesia in Australia. Ann Fr Anesth Reanim 1993;12:97-104.
3. Galleyly DC, Treuren BC. Anaphylactoid reaction during anaesthesia. Seven years experience the intradermal testing. Anaesthesia 1985;40:329-40.
4. Laxenaire MC (on behalf of a working party). Drugs and other agents involved in anaphylactid shock occurring during anaesthesia. A french multicenter epidemiological inquiry. Ann Fr Anesth Reanim 1993;12:91-6.
5. Laxenaire MC. Drugs and other agents involved anaphylactic shock occurring during anaesthesia anaphylactic shock occurring during anaesthesia. A french multicenter epidemiological inquiry. A Fr Anesth Reanim 1993;12:91-6.
6. Moscicki RA, Sockin SM, Corsello BF, et al. Anaphylaxis during induction of general anaesthesia: subsequent evaluation and management. J Allergy Clin Immunol 1990; 86:325-31.
7. Beaudouin E, Pupil P, Jacson F, et al. Allergie professionnelle au latex-Enquète prospective sur 907 sujects du milieu hospitalier. Rev Fr Allergol 1990;30:157-61.
8. Alam M, Anrep GV, Barsoum GS, Tallat M, Weineger E. Liberation of histamine from the skeletal muscle by curare. Journal of Physiology (London) 1939;95:148-58.
9. Evans F, Gluld J. Relation between sensitivity to thiopentone, sulphonamides and sunlight. BMJ 1952;1:417-9.
10. Association of Anaesthetists of Great Britain and Ireland. Anaphylactic reactions associated with anaesthesia. London: Association of Anaesthetists of Great Britain and Ireland; 1990.
11. Moss J, Roson CE, Savarese JJ, Philbin DM, Kniffen KJ. Role of histamine in the hypotensive action of d-tubocurarine in humans. Anaestesiology 1981;55:19-25.
12. Philbin DM, Moss J, Akins CW, et al.The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study. Anesthesiology 1981;55:292-6.
13. Lavery GGM, Clarke RSJ, Watkins J. Histaminoid responses to atracurium, vecuronium and tubocurarine. Ann Fr Anesth Reanim 1985;4:180-3.
14. Barnes PK, Reny-Martin N, Thomas VJE, Watkins J. Plasma histamine levels following atracurium. Anaesthesia 1986;41: 821-4.
15. Hosking MP, Lennon RC, Gronest GA. Comined H1 and H2 receptor blockade attenuates the cardiovascular effects of high-dose atracurium for rapid sequence endotracheal intubation. Anesth Analg 1988;67:1089-95.
16. Sniper N. The estimation and comparison of histamine release by muscle relaxants in man. Br J Anaesth 1952;24: 232-7.
17. Moneret-Veautrin DA, Laxenaire MC, Mouton C, Widmer S, Pupil P. Modification de la reactivité cutanée dans l'anaphylaxie aux myorelaxantes et hypnotiques après administration d'anti H1, d'anti H2 et de tritoqualine. Ann Fr Anesth Réanim 1985;4:225-30.
18. Booij LHDJ, Krieg N, Crul JF. Intradermal histamine releasing effect caused by Org-NV 45. Acta Anaesth Scand 1980;24: 393-4.
19. Levy JH, Adelson D, Walker B. Wheal and flare responses to muscle relaxants in humans. Agents Actions 1991;34:302-8.
20. Igea JM, Fernández M, Lázaro M, Vuevas M. Efecto liberador de histamina de los fármacos utilizados en la anestesia general. Rev Esp Alergol Inmunol Clin 1996;11:117-26.
21. Vervloet D, Nisanrowsra E, Arnaud A, et al. Adverse reactions to suxamethonium and other muscle relaxants under general anaesthesia. J Allergy Clin Immunol 1983;71:552-9.
22. Harle DG, Blado BA, Fisher MM. Detection of IgE antibodies to suamethonium after anaphylactic reactions during anaesthesia. Lancet 1984;1:930-2.
23. Baldo BA, Fisher MM. Anaphylaxis to muscle relaxants drugs: cross reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay. Mol Immunol 1983;20:1393-400.
24. Watkins J. Anaphylactoid reactions to IV substances. Br J Anaesth 1979;51:51-60.
25. Moudgil GC. Can Anaesth Soc J 1986;33:400-14.
26. Stoeling RK. Allergic reactions during anesthesia. Anesth Analg 1983;62:341-56.
27. Radford SG, Lockyer JA, Simpson PJ. Immunological aspects of adverses reactions to althesin. Br J Anaesth 1982;54:859-63.
28. Klatskin G, Kimberg DV. Recurrent hepatitis atributable to halothane sensitization in an anesthetist. N Engl J Med 1995; 280:515-6.
29. Paronetto F, Popper H. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med 1970;283:277-80.
30. Walton B, Dumonde DC, Williams C, et al. Lymphocyte transformation. Absece of increased responses in allerged haloyhone jaundice. JAMA 1973;225:494-8.
31. Vergani D, Tsantoulas D, Eddleston AL, et al. Demostration of sensitization to halothane altered liver components in patients with severe halothane hepatitis. Lancet 1979;2:801-3.
32. De Sware RD. Alergia a drogas. In: Roy P (eds.). Enfermedades alérgicas, diagnóstico y tratamiento. Madrid: Ediciones Cea: 1988. p. 505-660.
33. Parker CW. Major drugs acting on the central nervous system. In: De Week AL, Bundgaard H (eds.). Allergic reactions to drugs. London: Editorial Board; 1983. p. 243-58.
34. Task. Force on allergic reactions to latex: Committee Report. J Allergy Clin Immunol 1993;92:16-8.
35. Pepys J, Pepys EO, Baldo BA, Whitwam JG. Anaphylactic/ anaphylactoid reactions to anaesthetic and associated agents. Skin prick tests i aetiological diagnosis. Anaesthesia 1994;49:470-5.
36. Kwittken PL, Sweinberg SK, Campbell DE, Pawlowski NA. Latex hypersensitivity in children: clinical presentation and detection of latex-specific immunoglobulin E. Pediatrics 1995;95:693-9.
37. Blanco C, Carrillo T, Castillo R, Quiralte J, Cuevas M. Latex allergy: clinical features and cross-reactivity with frutis. Ann Allergy 1994;73:309-14.
38. McCormack DR, Heisser Al, Smith Ll. Intraoperative vecuronium anaphylaxis compounded by latex hipersensitivity. Ann Allergy 1994;73:405-8.
39. Kwittken PL, Sweinberg SK, Campbell DE, Pawlowski NA. Latex hypersensitivity in children: clinical presentation an detection of latex-specific immunoglobulin E. Pediatrics 1995;95:693-9.
40. Ring J, Messmer K. Incidence and severity of anaphilactoid reactions to colloid volume substitutes. Lancet 1977;i:466-9.
41. Laxenaire ME, Charpentierc, Feldman L. Anaphylactoid reactions to colloid plasma sustitutes: incidence, risk factors, mechanisms. A french multicenter prospective study. Ann Fr Anesth Réanirn 1994;13:301-10.
42. Lorenz W, Doenicke A, Messmer K, Reimann HJ, Thermann M, Lahn W, et al. Histamine release in human subjects by modified gelatin (haemaccel) and dextran: an explanation for anaphylactoid reactions observed under clinical conditions? Br J Anaesth 1976;48:151-65.
43. Lorenz W, Doenicke A, Schöning B, Ohmann C, Grote B, Neugebauer E. Definition and clasification of the histamine-release response to drugs in anaesthesia and surgery: studies in the conscious human subject. Klin Wochenschr 1982;60:896-913.
44. Watkins J, Thornton JA. Immunological and non-immunological mechanism involved in adverse reactions to drugs. Klin Wochenschr 1982;60:958-64.
45. Beaen MA, Robinson-White A, Roderick NB, Kauffman GL. The demostration of histamine release in clinical conditions: a review of past and present assay procedures. Klin Wochenschr 1982;60:873-81.
46. Moss J, Rosow CE. Histamine release by narcotics and muscle relaxants in humans. Anesthesiology 1983;59: 330-9.
47. Flacke JW, Flacke WE, Bloor BC, Van Etten APV, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987;66:723-30.
48. Moss J, Rosow CE, Savarese JJ, Philbin DM, Kniffen KJ. Role of histramine in the hypotensive action of d-tuborurarine in humans. Anesthesiology 1981;55:19-25.
49. Basta SJ, Moss J, Saverese JJ, et al. Cardiovascular effects of BW444V: correlation with plasma histamine levels. Anesthesiology 1981;55:A198.
50. Philbin DM, Moss J, Akins XW, et al. The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study. Anesthesiology 1981;55:292-6.
51. Tryba M, Triene M, Wruck G, Zenz M. Kardiovasculäre reaktionen und histaminfreisetzung nach atracurium - ein problem der dosis? Anaesthesist 1988;37:483-8.
52. Fisher MM, Baldo BA. Role of IgE in anaphylactoid reactions during anesthesia. Ann Fr Anesth Réanims 1985;4:133-6.
53. Stoeling RK. Allergic reactions furing anesthesia. Anesth Analg 1983;62:341-56.
54. Moneret-Vautrin DA, Lexenaire MC, Moeller R. Anaphylaxis due to succinylcholine. Immunoallergological study of thirteen cases. Clinical Allergy 1981;11:175-83.
55. Vervolet D, Arnaud A, Vellieux P, Kaplanski S, Charpin J. J Allergy Clin Immunol 1979;63:348-53.
56. Fisher MM. Intradermal testing in the diagnosis of acute anaphylaxis furing anaesthesia: results of five years experience. Anesth Intensive Car 1979;7:58-61.
57. Laxenaire MC, Moneret-Vautrin DA, Boileau S. Choc anaphylactique au suxaméthoniym. A propos de 18 cas. Ann Fr Anesth Réanim 1982;1:29-36.
58. Vervloet D, Nizankowska E, Arnaud A, Senft M, Alazia M, Charpin J. Adverse reactions to suxamethonium and other muscle relaxants under general anesthesia. J Allergy Clin Immunol 1983;71:552-9.
59. Moneret-Vautrin DA, Guéant JL, Kamel L, Laxenaire MC, Elkholty S, Nicolas JP. Anaphylaxis to muscle relaxants: cross-sensitivity studied by radioimmunoassays compared to intradermal tests in 34 cases. J Allergy Clin Immunol 1988;82:745-52.
60. Leynadier F, Sansarricq M, Didier JM, Dry J. Dépistage des allergiques aux myorelaxants par prick-tests préchargés. Presse Med 1986;15:2072.
61. Wood M, Watkins J, Wild G, Levy CJ, Harrington C. Skin testing in the investigation of reactions to intravenous anaesthetic drugs. A prospective trial of atracurrium and tubocurarine. Ann Fr Anesth Réanim 1985;4:176-9.
62. Lavery FF, Clarke RSJ, Watkins J. Histaminoid responses to atracurrium, vecuronium and tuborurarine. Ann Fr Anesth Réanim 1985;4:180-3.
63. Moneret-Vautrin DA, Mouton C, Widmer S. Anaphylaxie aux myorelaxants. Valeur prédictive des intradermoréactions et recherche de l'anaphylaxis croisée. Ann Fr Anesth Réanim 1985;4:186-91.
64. Didier A, Benzarti M, Senft M, et al. Allergy to suxamethomiym: persisting abnormalities in skin tests, specific IgE antibodies and leucocyte histamine release. Clin Allergy 1987;17:385-92.
65. Didier A, Benzarti M, Alazia M, et al. Accidents anaphylactiques au suxamethonium. Ann Fr Anesth Réanim 1986;5:361-6.
66. Assem ESK, Frost PG, Levis RD. Anaphylactic like reaction to suxamethenium. Anaesthesia 1981;36:405-10.
67. Facon A, Grosset P, Tonnel AB, Shcerpereel P. Intérêt des tests de liberation de l'histamine leucocytaire et des intradmroréactions dans le diagnsotic des accidents anaphylactoides aux produits anesthésiques. Ann Fr Anesth Réanim 1985;4:233-7.
68. Yougman PR, Taylor KM, Wilson JD. Anaphylactoid reactions to neuromuscular blocking agents: a commonly undiagnosed condition? Lancet 1983;10:597-8.
69. Fisher MM, Baldo BA. Role of IgE in anaphylactoid reactions during anaesthetic allergy. Ann Fr Anesth Réanim 1985;4: 192-4.
70. Laxenaire MC. Prévention des réactions anaphylactoides peranesthésiques. Ann Fr Anesth Réanim 1985;4:99-100.
71. Laxenaire MC, Manel J, Borgo J, Moneret-Vautrin DA. Facteurs de risque d'histaminoliberation: étude prospective dans une population anesthésiée. Ann Fr Aneths Réanim 1985;4:158-66.
72. Galletly DC, Treuren BC. Anaphylactoid reactions during anaesthesia. Seven years experience of intradermal testing. Anaesthesia 1985;40:329-33.
73. Fisher MM. Anaphylaxis to muscle relaxants. Cross sensitivity between relaxants. Anaesth Intensive Care 1980;8:211-3.
74. Gueant JL, Kamel L, Moneret-Vautrin DA, Widmer S, Laxenaire MC, Nicolas JP. Radioimmunoassay method for the detection of IgE antibodies specific to alcuronium. Ann Fr Anesth Réanim 1986;5:570-3.
75. Moneret-Vautrin DA, Laxenaire MC, Mouton C. Anaphylaxis crosée avec le vécuronium. Ann Fr Anésth Reánim 1984;3:467-70.
76. Vergnenegre A, Bataille A, Bonnaud F, Eichler B, Germouty J. Skin tests in the exploration of perianesthetic complications. Allerg Immunol 1986;18:29-34.
77. Fisher MM. Reaginic antibodies to drugs used in anesthesia. Anesthesiology 1980;52:318-20.
78. Boileau S, Hummer Sigiel M, Moeller R, Drouet N. Reévaluation des risques respectifs d'anaphylaxie et d'histaminolibération avec les substances anesthésiologiques. Ann Fr Anesth Réanim 1985;4:195-204.
79. Moudgil GC. Can Anaesth Soc J 1986;33:400-14.
80. Fisher MM, Baldo BA. Role of IgE in anaphylactoid reactions during anaesthesia. Ann Fr Anesth Réanim 1985;4:192-4.
81. Symons NLP, Hobes AFF, Leaver HK. Anaphylactoid reactions to vancomycin during anaesthesia: two clinical reports. Can Anaesth Soc J 1985;32:178-81.
82. Vervloet.
83. Baldo BA, Harle DG, Fisher MM. In vitro diagnosis and studies on the mechanism of anapylactoid reactions to muscle relaxant drugs. Ann Fr Anest Réanim 1985;4:139-45.
84. Fisher M. Intradermal testing in the dignosis of acure anaphylaxis during anaesthesia: results of five years experience. Anaesth Intensive Care 1979;7:58-61.
85. Harle DG, Baldo BA, Fisher MM. Assays for, and cross-reactivities of, IgE antibodies to the muscle relaxants gallamine, decamethomium and succinylcholine (suxamethonium). Journal of Immunological Methods 1985;78:213-305.
86. Didier A, Cador D, Bongrand P, et al. Role of the quaternary amonium ion determinants in allergy to muscle relaxants. J Allergy Clin Immund 1987;79:578-84.
87. Harle DG, Baldo BA, Fisher MM. Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular bas sis of binding of IgE antibodies detected by radioimmunoassay. Molecular Immunology 1983;20:1393-400.
88. Harle DG, Baldo BA, Smal MA, Wajon P, Fisher MM. Detection of thiopentone-reactive IGE antibodies following anaphylactoid reactions during anaesthesia. Clin Allergy 1986;16:493-8.
89. Harle DG, Baldo BA, Smal MA, Fisher MM. Drugs as allergens: the molecular basis of IgE binding to thiopentone. Int Arch Allergy Appl Immunol 1987;84:277-83.
90. Wstkins J. Investigation of alergic and hypersensitivity reactions to anaesthetic agents. Br J Anaesth 1987;59:104-11.
91. Segalen C, Hieblot C, Claquin C, Lavigne F, Benveniste J. Human basophyl degranulation test in the diagnosis and prevention of peranesthetic anaphylactoid diagnosis and prevention of peranesthetic anaphylactoid complications. Ann Fr Anesth Réanim 1986;5:356-60.
92. Drouet M, Sabah A, Le Sellin J, Bonneau JC. Complications induced by general anesthetics. Allerg Immunol 1986;18:23-7.
93. Laxenaire MC, Moneret-Vautrin DA, Watkins J. Diagnosis of the causes of anaphylactoid anaesthetic reactions. A report of the recommendations of the joint anaesthetic and immuno-allergological workshop, Nancy, France: 19 March 1982. Anaesthesia 1983;38:147-8.
94. Lorenz W, Doenicke A, Schoning B, Ohmann CH, Grote B, Neugebauer E. Definition and clasification of the histamine-release response to drugs in anaesthesia and durgery: studies in the conscious human subject. Klin Wochenschr 1982;60:896-913.
95. Birnbaum J, Vervloet in Assem E-SK (ed). Allergic reactions to anaesthetics. Clinical and basic aspects. Monogr Allergy 1992;30:15-23.
96. Moscicki RA, Sockin SM, Corsello BF, et al. Anaphylaxis during induction of general anaesthesia: subsequent evaluation and management. J Allergy Clin Immunol 1990;86:325-31.
97. Beaudouin E, Pupil P, Jacson F, et al. Allergie professionnelle au latex-Enquête prospective sur 907 sujets du milieu hopitalier Rev Fr Allergol 1990;30:157-61.
98. Fisher M, Outhred A, Bowley CJ. Can clinical anaphylaxis to anesthetic drugs be predicted from allergic history? Brt J Anaesth 1987;59:690-2.
99. Moneret-Vautrin DA, Beaudouin F, Widmer S, et al. Prospective study of risk factors in natural rubber latex hypersensitivity. J Allergy Clin Immunol 1993;92:668-77.
100. Schnider SM, Papper EM. Anesthesia for the asthmatic patient. Anestesiology 1961;22:886-9.
101. Fisher M, Nore DG. The epidemiology and clinical features of anaphylactic reactions in anesthesia. Anesth Intensive Care 1981;9:226-34.
102. Moneret-Vautrin DA, Laxenaire MC. The risk of allergy related to general anaesthesia. Clin Exp Allergy 1993;23:629-33.
103. Tarlo M, Wong L, Roos J, Booth N. Occupational asthma caused by latex in a surgical glove manufacturing plant. J Allergy Clin Immunol 1990;85:626-31.
104. Vervloet D. Allergy to muscle relaxants and related compounds. Clinical Allergy 1985;15:501-8.
105. Moneret-Vautrin DA, Laxenaire MC, Boileau S, Grilliat JP, Widmer S, Croizier A. Facteurs de risque des reactions anaphylactoides aux myorelaxants. Etude retrospective a partir de 103 chocs. Ann Fr Anesth Réanim 1985;4:152-7.
106. Moneret-Vautrin DA, Mouton C. Anaphylaxie aux myorelaxants. Valeur prédictides intradermoréactions et recherche de lénaphylaxie croisée. Ann Fr Anesth Réanim 1985;4:186.
107. Lavery GG, Clarke RSJ, Watkins J. Histaminod responses to atracurium, vecuronium and tucocurarine. Ann Fr Anesth Réanim 1985;4:180-3.
108. Wood M, Watkins J, Wild G, Levy CJ, Harrington C. Skin testing in the investigation of reactions to intravenous anaesthetic drugs. A prospective trial of atracurium and tubocurarine. Ann Fr Anesth Réanim 1985;4:176-9.
109. Fisher MM, Ooothered A, Bowey CJ. Can clinical anaphylaxis to anaesthetic drugs be predicted from allergic history? Br J Anaesth 1987;59:690-2.
110. Fisher MM. Skin testing in the preoperative diagnosis of anaesthetic allergy. Ann Fr Anesth Réanim 1985;4:192-4.
111. Viutton D, Neidhardt-Audion M, Girardin P, et al. Caractéristiques epidémiologiques de 21 accidents anaphylactoides peranesthésiques observés dans une population de 12.855 sujets operés. Ann Fr Anesth Réanim 1985;4:167-72.
112. Laxenaire MC, Gueant JL, Moneret-Vautrin DA. Histamine release in vivo and in vitro induced by hypnotics in normal and atopic patients. Agents Actions 1992;36:172-6.
113. Villas Martinez F, Jural A, Garmendia FJ. Reacción anafiláctica en la inducciön cunestésica con propofol. Rev Esp Alergol Inmunol Clin 1967;12:364-6.
114. Powell JR, Brrody MJ. Identification and specific blockade of two receptors for histamine in the cardiovascular system, J Pharmacol Exp Ther 1976;196:1-14.
115. Rosow CE, Basta SJ, Savarese JJ, et al. BW785V: correlation of cardiovascular effects with increases in plasma histamine. Anesthesiology 1980;53:5270.
116. Lien CA, Belmont MR, Abalos A, et al. The cardiovascular effects and histamine releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82:1131-8.
117. Moos J, Philbin DM, Rosow CE, Basta SJ, Gelb C, Savarese JJ. Histamine release by neuromuscular blocking agents in man. Klin Wochenschr 1982;60:891-5.
118. Lorenz W, Sitter H, Stinner B, et al. Controlled clinical trials and cross-sectional studies with plasmhistamine measurements and histamine receptive antagonists: solving the problem of preoperative H1±H2-prophylaxis by asking new questions. Agents Actions 1991;33 Supl:197-230.
119. Besredka A. Comment epêcher lánaphylaxie. Comptesrendus. Hebdomadaire des Séances de la Société de Biologie; 1907. p. 87-118.
120. Treuren BC, Galletly DC, Robinson BJ, Sohrt TG, Ure RW. The influence of the H1 and H2 receptor antagonists, terfenadine and ranitidine on the hypotensive and gastric pH effects of the histamine releasing drugs, morphine and d-tubocurarine. Anaesthesia 1993;48:758-62.
121. Doenicke A, Lorenz W. Anti H1 - and anti H2-pre-medication. Ann Fr Anesth Réanim 1985;4:214-20.
122. Ljungstrom KG, Renck H, Hedin H, Richter W, Rosberg B. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. I.A. Scandinavian multicenter study on the effects of 10 ml dextran 1, 15% administered before destran 70 or dextran 40. Acta Chir Scand 1983;149:341-8.
123. The use of epinephrine in the treatment of anaphylaxis academy of allergy and Immunology Board of Directors. J Allergy Clin Immunol 1994;94:666-8.
124. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1986;14:17-21.